ウイルス濾過の世界市場：濾過キット、試薬、装置、サービス...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 27)

4 Premium Insights (Page No. – 32)
4.1 Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 36)
5.1 Introduction
5.1.1 By Product
5.1.2 By Application
5.1.3 By End User
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing R&D Spending
5.2.1.2 Growth in Biopharmaceutical Industry
5.2.1.3 Increasing Government Support for the Pharmaceutical & Biotechnology Industry
5.2.2 Restraints
5.2.2.1 Stringent Regulations for Validation of Filtration Products
5.2.2.2 Highly Consolidated Market
5.2.3 Opportunities
5.2.3.1 Asia Presents High-Growth Opportunities
5.2.3.2 Increasing Pharmaceutical Outsourcing
5.2.4 Trend
5.2.4.1 Rising Adoption of Single-Use Technologies

6 Virus Filtration Market, By Product (Page No. – 46)
6.1 Introduction
6.2 Kits and Reagents
6.3 Filtration Systems
6.4 Services
6.5 Other Products

7 Virus Filtration Market, By Application (Page No. – 55)
7.1 Introduction
7.2 Biologicals
7.2.1 Vaccines and Therapeutics
7.2.2 Blood and Blood Products
7.2.3 Cellular and Gene Therapy Products
7.2.4 Tissue and Tissue Products
7.2.5 Stem Cell Products
7.3 Medical Devices
7.4 Water Purification
7.5 Air Purification

8 Virus Filtration Market, By End User (Page No. – 72)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Contract Research Organizations
8.4 Academic Research Institutes
8.5 Medical Device Companies

9 Virus Filtration Market, By Region (Page No. – 82)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia (RoA)
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 135)
10.1 Introduction
10.2 Strategic Overview
10.3 Market Share Analysis
10.4 Competitive Situation and Trends
10.4.1 New Product Launches and Upgrades
10.4.2 Agreements, Collaborations, and Partnerships
10.4.3 Mergers & Acquisitions
10.4.4 Expansions

11 Company Profiles (Page No. – 142)
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Introduction
11.2 Merck Kgaa
11.3 General Electric Company
11.4 Thermo Fisher Scientific, Inc.
11.5 Lonza Group Ltd.
11.6 Pall Corporation
11.7 Charles River Laboratories International, Inc.
11.8 Sigma-Aldrich Corporation
11.9 Sartorius AG
11.10 Asahi Kasei Medical Co., Ltd.
11.11 Wuxi Pharmatech (Cayman) Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 177)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports